stockrowFreenome, Inc (FRNM) vs Myriad Genetics, Inc. (MYGN)
- Freenome, Inc FRNM 10.47 −7.35%
- Myriad Genetics, Inc. MYGN 6.19 +2.82%
Freenome, Inc and Myriad Genetics, Inc. are both Diagnostics & Research companies. Freenome, Inc is the larger, with a market value of $1.1B against $601.6M — 1.9× the size. Freenome, Inc has the higher net margin (0.00% vs −14.0%) and the higher return on invested capital (0.00% vs −19.9%). Across the 12 metrics below, Freenome, Inc leads on 10 and Myriad Genetics, Inc. on 2.
Valuation
Profitability
| Metric | FRNM | MYGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | — | 68.83% | 48.32% |
| Operating margin | 0.00% | (12.22%) | (5.68%) |
| Net margin | 0.00% | (13.96%) | (4.10%) |
| Free cash flow margin | 0.00% | (1.76%) | 0.00% |
| Return on equity | 17.81% | (32.54%) | 0.00% |
| Return on assets | (0.86%) | (17.11%) | (6.05%) |
| Return on invested capital | 0.00% | (19.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack